Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | CCS1477 |
Trade Name | |
Synonyms | CCS-1477|CCS 1477 |
Drug Descriptions |
CCS1477 binds to and inhibits p300 (EP300) and CBP (CREBBP), potentially resulting in decreased tumor cell proliferation and inhibition of tumor growth (J Clin Oncol 35, 2017 (suppl; abstr 11590)). |
DrugClasses | CBP/p300 inhibitor 11 |
CAS Registry Number | 2222941-37-7 |
NCIT ID | C160195 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Abiraterone + CCS1477 | Abiraterone CCS1477 | 0 | 1 |
CCS1477 | CCS1477 | 0 | 2 |
CCS1477 + Enzalutamide | CCS1477 Enzalutamide | 0 | 1 |